- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02764658
Proteoglycan 4 Mechanism the Effectiveness of Pulmaonry Recovery in COPD Patients
Studies in Pulmonary Inflammation and the Effectiveness of Pulmonary Recovery in COPD Patients:the Mechanism of Proteoglycan 4
Study Overview
Status
Conditions
Detailed Description
The investigators previous research has demonstrated that proteoglycan 4 (PRG4) may be a biomarker for identification of severity in COPD. PRG4 was more sensitive and specific than CRP for confirming COPD severity and acute exacerbation frequency. It was related to the 1-year force vital capacity decline in COPD patients. The past study found that Prg4 is an immunomodulatory factor regulating parathyroid hormone actions on hematopoietic cells in mice. Previous report showed that voluntary wheel running and fluid flow shear stress that promote the expression of the Prg4 and association with pulmonary inflammation. COPD patients are characterized by a progressive decrease of lung function that is associated with increased in the airway and systemic inflammation. Pulmonary recovery (PR) is able to decrease acute exacerbation, maintain pulmonary function, increase exercise tolerance and improve quality of life in COPD patients, but it is unknown the mechanism of PRG4. The current study aimed to study in the pulmonary inflammation and the effectiveness of pulmonary recovery in COPD Patients:The mechanism of PRG 4.
Proteoglycan 4 is correlated with pulmonary inflammation and decline of pulmonary function in the different phenotype of COPD.
1-1 Classification of characteristic、the severity of disease、pulmonary functional test、exercise capacity and blood sample collection for routine analysis.
1-2 Human blood bio-bank and molecular analysis: PRG4、IL-6、IL-8、TNFα、CRP& IL-10.
1-3 To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in COPD patients.
The mechanism of PRG 4 in the effectiveness of PR on the AECOPD. 2-1 The PR program: The combination effect of negative pressure ventilation and exercise training program on acute exacerbation of COPD (AECOPD).
2-2 To examine the efficacy of PR on cytokines and PRG4 protein. 2-3 Correlation between PR effects and PRG4:PR is correlation with PRG4、clinical progression、exercise tolerance、PFT change and SpO2 during exercise.
In vitro cell culture research models 3-1 Pulmonary inflammatory model establishment:Human primary epithelium cell culture and Beas-2B for IL-1β、TNFα、LPS、IL-10 and H2O2 effects.
3-2 Purification of peripheral blood monocyte cells:Primary culture to evaluate pulmonary inflammation and treatment effects.
3-3 Hypoxia experiments:To test whether hypoxia induces regulation of PRG4 protein or different cytokines in epithelial cells.
3-4 Inhibit PRG4:To prove the mechanism of PRG4 under the hypoxia model by PRG4 siRNA。
- In vivo animal research models 4-1 Smoke-COPD mice models establishment: 4-2 To determinate the effects of exercise training in COPD mine. 4-3 To investigate on PRG4 protein in pulmonary inflammation and the effectiveness of exercise training in the tissue and serum of mice.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Hospitalized patients with acute exacerbation of COPD
- GOLD diagnostic criteria based on the COPD, the use of inhaled bronchodilators: the first second forced expiratory volume (FEV1.0) / forced vital capacity (FVC) <70%.
- Age ≧ 40 and ≦ 80 years old, is currently not accepting any research project.
- Physician assess the patient is currently in stable condition vital signs, complain dyspnea of exercise, consult RT for pulmonary rehabilitation.
- The purpose of this study by researchers explain, the researchers agreed to participate in this.
Stable COPD outpatients
- GOLD diagnostic criteria based on the COPD, the use of inhaled bronchodilators: the first second forced expiratory volume (FEV1.0) / forced vital capacity (FVC) <70%.
- Age ≧ 40 and ≦ 80 years old, is currently not accepting any research project.
- The purpose of this study by researchers explain, the researchers agreed to participate in this.
Exclusion Criteria:
Hospitalized patients with acute exacerbation of COPD
- Unstable vital signs: blood pressure <90 mm Hg, blood oxygen levels (SpO2) at Tx under still <85%.
- Associated with neuromuscular function disorders such as hemiplegia or no independent walking function.
- Have been diagnosed with severe mental disorders, such as dementia or or unable to cooperating people.
Stable COPD outpatients
- Over the past three months there have been acute infection or are in a state of acute attacks.
- Associated with neuromuscular function disorders such as hemiplegia or no independent walking function.
- Have been diagnosed with severe mental disorders, such as dementia or unable to cooperating people
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Pulmonary recovery on the AECOPD
Study in the pulmonary inflammation and the effectiveness of pulmonary recovery in AECOPD Patients
|
The combination effect of negative pressure ventilation, limb muscle exercise training program and fibit monitor on acute exacerbation of AECOPD.
To investigate the daily physical activity in routine care patients with after AECOPD and stable stage.
Other Names:
To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Routine care patients wtih AECOPD and stable stage.
Other Names:
To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Non-Pulmanary recovery patients wtih stable COPD.
Other Names:
|
OTHER: Routine care on the AECOPD
Study in the pulmonary inflammation and the effectiveness of pulmonary recovery in AECOPD Patients
|
To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Routine care patients wtih AECOPD and stable stage.
Other Names:
To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Non-Pulmanary recovery patients wtih stable COPD.
Other Names:
|
OTHER: Routine care on the stable COPD
Study in the pulmonary inflammation and the effectiveness of pulmonary recovery in stabel COPD Patients
|
To investigate whether daily physical activity、hypoxia and hyperinflation were associated with airway inflammation and PRG4 in Non-Pulmanary recovery patients wtih stable COPD.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The systemic inflamation biomakers
Time Frame: 0~12 months
|
Measured the proteaglycan4、IL-6、IL-8、TNFα、CRP& IL-10 from the supernatant with COPD patients
|
0~12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise capacity
Time Frame: 0~12 months
|
Six-minute walking distance and lung
|
0~12 months
|
The correlaton with the exercise capacity and systemic inflammationcytokines
Time Frame: 0~12 months
|
volumePulmonary recovery is correlation with PRG4、clinical progression、exercise tolerance、PFT change and SpO2 during exercise
|
0~12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shu-Chuan Ho, School of Respiratory Therapy, College of Medicine, Taipei Medical University
Publications and helpful links
General Publications
- Ho SC, Lin HC, Kuo HP, Chen LF, Sheng TF, Jao WC, Wang CH, Lee KY. Exercise training with negative pressure ventilation improves exercise capacity in patients with severe restrictive lung disease: a prospective controlled study. Respir Res. 2013 Feb 19;14(1):22. doi: 10.1186/1465-9921-14-22.
- Lee KY, Chuang HC, Chen TT, Liu WT, Su CL, Feng PH, Chiang LL, Bien MY, Ho SC. Proteoglycan 4 is a diagnostic biomarker for COPD. Int J Chron Obstruct Pulmon Dis. 2015 Sep 18;10:1999-2007. doi: 10.2147/COPD.S90926. eCollection 2015.
- Wang CH, Chou PC, Joa WC, Chen LF, Sheng TF, Ho SC, Lin HC, Huang CD, Chung FT, Chung KF, Kuo HP. Mobile-phone-based home exercise training program decreases systemic inflammation in COPD: a pilot study. BMC Pulm Med. 2014 Aug 30;14:142. doi: 10.1186/1471-2466-14-142.
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TMU-JIRB Ho1.2/20160212
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Peking University First HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Shandong Provincial Hospital and other collaboratorsRecruiting
-
Hôpital NOVORecruiting
-
Rigshospitalet, DenmarkRecruiting
-
NHS Greater Glasgow and ClydeLenus Health; University of Glasgow Robertson Centre for Bio StatisticsRecruiting
-
Xemed LLCUniversity of Pennsylvania; Temple UniversityNot yet recruiting
-
Erasme University HospitalRecruiting
-
Istituti Clinici Scientifici Maugeri SpARecruiting
-
Temple UniversityGlaxoSmithKlineNot yet recruiting
Clinical Trials on Pulmonary recovery on the AECOPD
-
Sociedad Española de Neumología y Cirugía TorácicaEuropean Commission; SAVANAUnknownChronic Obstructive Pulmonary DiseaseSpain, Austria, Switzerland, United Kingdom
-
Ihedioha, Ugo, M.D.CompletedColorectal Surgery | Use of Video EducationUnited Kingdom
-
NYU Langone HealthCompletedPulmonary TBUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingDisorder; Heart, Functional, Postoperative, Cardiac SurgeryCanada
-
Istituti Clinici Scientifici Maugeri SpARecruiting
-
National Cheng-Kung University HospitalCompleted
-
Lundquist Institute for Biomedical Innovation at...RecruitingLong Haul COVID or Post Acute Sequella of COVID - PASC (U09.9)United States